Insider trade

Director received an award of 645 CME shares

Traded Jun 25, 2026 · Filed Jun 29, 2026

CME GroupCME

645
Shares · @ $225.00

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 25, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 29, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001212853-26-000003
Filed / recorded

Jun 29, 2026, 8:24 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

CME GROUP INC.

Issuer CIK

1156375

Ticker

CME

Reporting person

Howard J Siegel

Relationship

Director

Security

Common Stock Class A

Table

Non-derivative (Table I)

Transaction date

Jun 25, 2026

Transaction code

A

Shares / units

645

Price per share

$225.00

Acquired / disposed

Acquired (A)

Shares owned after

48,436

Ownership form

Direct

Amendment

No

Footnotes from the filing

Represents a grant of fully vested shares of Class A Common Stock issued to the Reporting Person as part of the Issuer's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan. These shares are not subject to any vesting conditions.